Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Herrmann

Showing results (541-550 of 773) with videos related to

Pageof 78
Sort By:
The British Journal of Radiology|January 25, 2002
The influence of different technique factors on image quality of chest radiographs as evaluated by modified CEC image quality criteriaB Lanhede, M Båth, S Kheddache, et al.
Proteomics|September 16, 2003
Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancerPaul C Herrmann, John W Gillespie, Lu Charboneau, et al.
The American Journal of Cardiology|January 15, 1990
Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failureM A Fifer, C R Molina, A C Quiroz, et al.
The American Journal of Cardiology|May 29, 2002
Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary interventionHoward C Herrmann, Tomasz A Swierkosz, Shiv Kapoor, et al.
Circulation|June 12, 2002
Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-upMarco Roffi, David J Moliterno, Bernhard Meier, et al.
Journal of the American College of Cardiology|May 21, 2016
Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve ReplacementSuzanne J Baron, Suzanne V Arnold, Howard C Herrmann, et al.
Journal of Cardiac Surgery|August 18, 2009
Late surgical mitral valve repair after percutaneous repair with the MitraClip systemJason H Rogers, Khung Keong Yeo, John D Carroll, et al.
Circulation. Cardiovascular Interventions|June 2, 2025
Evaluation of Bioprosthetic Valve Dysfunction in the SMART Randomized Clinical TrialHoward C Herrmann, Daniel J Blackman, Guilherme F Attizzani, et al.
JACC. Cardiovascular Interventions|October 24, 2009
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitalsHoward C Herrmann, Jiandong Lu, Bruce R Brodie, et al.
Journal of the American College of Cardiology|September 19, 2003
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trialMitchell J Ross, Howard C Herrmann, David J Moliterno, et al.
Pageof 78

Showing results (541-550 of 773) with videos related to

Sort By:
Pageof 78
The British Journal of Radiology|January 25, 2002
The influence of different technique factors on image quality of chest radiographs as evaluated by modified CEC image quality criteriaB Lanhede, M Båth, S Kheddache, et al.
Proteomics|September 16, 2003
Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancerPaul C Herrmann, John W Gillespie, Lu Charboneau, et al.
The American Journal of Cardiology|January 15, 1990
Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failureM A Fifer, C R Molina, A C Quiroz, et al.
The American Journal of Cardiology|May 29, 2002
Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary interventionHoward C Herrmann, Tomasz A Swierkosz, Shiv Kapoor, et al.
Circulation|June 12, 2002
Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-upMarco Roffi, David J Moliterno, Bernhard Meier, et al.
Journal of the American College of Cardiology|May 21, 2016
Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve ReplacementSuzanne J Baron, Suzanne V Arnold, Howard C Herrmann, et al.
Journal of Cardiac Surgery|August 18, 2009
Late surgical mitral valve repair after percutaneous repair with the MitraClip systemJason H Rogers, Khung Keong Yeo, John D Carroll, et al.
Circulation. Cardiovascular Interventions|June 2, 2025
Evaluation of Bioprosthetic Valve Dysfunction in the SMART Randomized Clinical TrialHoward C Herrmann, Daniel J Blackman, Guilherme F Attizzani, et al.
JACC. Cardiovascular Interventions|October 24, 2009
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitalsHoward C Herrmann, Jiandong Lu, Bruce R Brodie, et al.
Journal of the American College of Cardiology|September 19, 2003
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trialMitchell J Ross, Howard C Herrmann, David J Moliterno, et al.
Pageof 78